Jens Wiebe

10PUBLICATIONS
23CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Women's studies (incl. girls' studies)BiomaterialsCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 30, 2025
Ten-Year Outcomes of Patients with Left Main Coronary Artery Disease and Diabetes Mellitus Treated with Percutaneous Coronary Intervention.

Jola Bresha, Gjin Ndrepepa, Constantin Kuna

|Nov 25, 2025
Clinical outcomes of drug-coated balloon vs. second-generation drug-eluting stent for coronary in-stent restenosis.

J Krefting, N Krüger, C Friess

|Feb 03, 2025
Sex-related outcomes after percutaneous coronary intervention of in-stent restenosis.

Constantin Kuna, Christian Bradaric, Mira Schroeter

|Oct 16, 2024
A Prospective, Randomized Trial of Bioresorbable Polymer Drug-Eluting Stents versus Fully Bioresorbable Scaffolds in Patients Undergoing Coronary Stenting.

Jens Wiebe, Robert A Byrne, Christian Bradaric

|Nov 18, 2021
A prospective trial of a novel low-dose paclitaxel-coated balloon therapy in patients with restenosis in drug-eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-stent REstenosis 3A (ISAR-DESIRE 3A).

Sebastian Kufner, Himanshu Rai, Jens Wiebe

|Aug 31, 2021
Outcomes of 10,312 patients treated with everolimus-eluting bioresorbable scaffolds during daily clinical practice - results from the European Absorb Consortium.

Jens Wiebe, Felix J Hofmann, Nick West

Pageof 2

Frequent Collaborators

2 joint publications

Heribert Schunkert

2 joint publications

Sebastian Kufner

2 joint publications

Stylianos Pyxaras

2 joint publications

Niklas Boeder